C
Cromodata
Secure Real World Data platform for healthcare
About Cromodata
Cromodata is an Argentine healthtech startup that has developed a collaborative platform to structure and anonymize clinical information from hospitals and diagnostic centers across Latin America. The company was founded by Keila Barral Masri (CEO), Matías Karlsson (CTO), and Juan Pablo Merea (COO). The inspiration for Cromodata came from CEO Keila Barral Masri's personal seven-year journey to receive a diagnosis for a medical condition, which she realized was due to her health data being fragmented across different providers. This experience, shared by other team members who are also patients, fuels the company's mission to connect health data for timely diagnoses.
The platform addresses the underrepresentation of Latin American data in global healthcare AI development, where it currently accounts for less than 1%. Cromodata connects data generators, such as clinics and hospitals, with data consumers like pharmaceutical companies, tech innovators, and researchers. The business model involves monetizing the anonymized data, which provides a new revenue stream for healthcare institutions and gives data consumers access to high-quality, diverse datasets for training AI models and accelerating research. Cromodata charges a fee for sourcing, anonymizing, securing, and linking the data between parties. The company's technology ensures data is encrypted and anonymized at the source, complying with international privacy standards like HIPAA, GDPR, and ISO 27001. This allows for the tokenization of patient identities, enabling the linking of records from different institutions without revealing personal information.
As of October 2025, Cromodata works with 47 hospitals across five countries—Argentina, Brazil, Uruguay, the Dominican Republic, and Mexico—and has processed over 20 million anonymized patient records. The company recently closed a pre-seed funding round of $1.2 million, led by PharmStars Ventures, a fund backed by major pharmaceutical companies including Pfizer and Roche. This investment will support its expansion and efforts to build a comprehensive health data ecosystem for the region.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Founded
- 2023
- Headquarters
- Buenos Aires, Argentina
- Employees
- 15
- Open positions
- None listed
- Dealroom signal
- 72.9/100
- Industry
- Health
- Sub-industry
- Health Platform
- Sector
- Health Tech & Medtech, Medical Data, Privacy-Enhancing Technologies
- Business model
- SaaS
- Client focus
- b2b
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SEED✓Equity / VC | Oct 2025 | $1.2M | $4.8M | Sands Capital Management · Maria Gabriela Pittis · PharmStars Ventures | ↗ |
Growth signals
Latest recorded traffic for Cromodata is 310 monthly website visits, up 520% over the last three months. Cromodata's team grew 150% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
| Company | Headquarters | Status | Employees | Total funding | Valuation |
|---|---|---|---|---|---|
Celato.aiGoverned real-world evidence from decentralized clinical data. |
— | Operational | — | — | — |
DatamedcoAnonymized healthcare data monetization and ransomware protection. |
Bogota, Colombia | Operational | |||
AlmaHealthDBCompliant infrastructure for sensitive clinical data research. |
Bologna, Italy | Operational | |||
Z K O M IAI-native systems for individual health data continuity. |
Zurich, Switzerland | Operational | |||
OshimedBlockchain eConsent management for clinical trials |
Namur, Belgium | Operational | |||
PontiroAutomated medical imaging anonymisation for compliant data sharing. |
Newport, United Kingdom | Operational | |||
veilAI engine for health data anonymization and synthetization |
— | Operational | |||
HONICSGDPR-compliant health data platform for medical research |
Riga, Latvia | Operational |
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed3 investors entered at this stage
PharmStars Ventures
Sands Capital Management- MPMaria Gabriela Pittis
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Cromodata on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Cromodata’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.







